Atlas Trials

Non-Interventional Study of Xeloda (Capecitabine) in Patients With Gastric Cancer

Clinical trial NCT02274376 · COMPLETED

Trial details

NCT number
NCT02274376
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Study type
OBSERVATIONAL
Gastric Cancer
Start date
2008-08-01
Primary completion
2012-12-01
Enrollment
223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.